Nevirapine not recommended for prophylaxis of HIV-1 infection

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1301, 2001-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nevirapine not recommended for HIV postexposure prophylaxis

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Nevirapine unsafe for HIV-1 infection prophylaxis?

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Efavirenz and Nevirapine in HIV-1 Infection: Is There a Role for Clinical Pharmacokinetic Monitoring?

By Dahri Karen Ensom Mary H.H.

Clinical Pharmacokinetics, Vol. 46, Iss. 2, 2007-01 ,pp. : 109-132

Adis International

Access to resources Recommend Favorite

Interruption of secondary prophylaxis in HIV infection

Inpharma, Vol. 1, Iss. 1360, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

The role of nevirapine in the treatment of HIV-1 disease

By Fumero Emilio Podzamczer Daniel

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. : 2065-2078

Informa Healthcare

Access to resources Recommend Favorite